Valneva SE Files 6-K Report
Ticker: VALN · Form: 6-K · Filed: Apr 28, 2025 · CIK: 1836564
| Field | Detail |
|---|---|
| Company | Valneva Se (VALN) |
| Form Type | 6-K |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
TL;DR
Valneva SE filed a routine 6-K, no major news.
AI Summary
Valneva SE filed a Form 6-K on April 28, 2025, reporting its status as a foreign private issuer. The company, incorporated in France, is in the business of biological products. This filing is in accordance with the 1934 Securities Exchange Act.
Why It Matters
This filing indicates Valneva SE is adhering to its reporting obligations as a foreign private issuer with the SEC, providing transparency to investors.
Risk Assessment
Risk Level: low — This is a standard regulatory filing for a foreign private issuer and does not contain new financial or operational information.
Key Players & Entities
- Valneva SE (company) — Registrant
- April 28, 2025 (date) — Filing Date
- 001-40377 (other) — Commission File Number
- 6 rue Alain Bombard 44800 Saint-Herblain, France (address) — Principal Executive Office
FAQ
What type of company is Valneva SE?
Valneva SE is a company in the business of biological products, specifically SIC code 2836.
What is the purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
When was this Form 6-K filed?
This Form 6-K was filed on April 28, 2025.
Does Valneva SE file annual reports under Form 20-F or 40-F?
Valneva SE indicates it files annual reports under cover of Form 20-F.
What is Valneva SE's principal executive office address?
Valneva SE's principal executive office is located at 6 rue Alain Bombard, 44800 Saint-Herblain, France.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 28, 2025 regarding Valneva SE (VALN).